30 July 2020
Visiongain has launched a new report Population Health Management Market Report 2020-2030: Forecasts by Component (Software, Services), Mode of Delivery (On-premise, Cloud-based), End-user (Healthcare Providers, Healthcare Payers, Others), and by Region (North America, Europe, Asia Pacific, Latin America & MEA), Including Forecasts by Major Developed Countries and Developing Countries, Plus Profiles of Leading Companies.
Population health management is a collection of patient data that has been obtained from various resources. It is used to monitor the patient condition and categorize them based on the common medical conditions and attributes. The collection and analysis of patient data helps to healthcare providers enhance the financial and clinical outcomes for the patient. These data is also utilized healthcare payers to assess and manage reimbursement policies and check the risks associated with it. Population health management improves the management of patient care as it helps to enhance patient communication, care coordination, and risk stratification.
Healthcare providers is the dominant segment in the population health management market as these solutions helps in better disease management and enhance patient outcomes. This results in decreasing the number of hospital days for patient and reduces the required physician hours, thus helping physicians concentrate on patient-centric care. Population health management also help healthcare payers with implementation of value-based reimbursement by aiding in interpretation of population behaviour and analyse unstructured clinical content.
There is an increase in preference for value-based reimbursement and patient-centric healthcare. As per the value-based reimbursement policies, the healthcare buyers and payers hold the healthcare delivery systems responsible to improve the patient outcome by providing better quality patient care. The increase in the patient data and increase in the prevalence of chronic diseases have led to an increase in the complexity of clinical needs, care delivery, and payment models. This has resulted in the increased demand for population health management programs with multiple functionality to deal with the operational, clinical, and financial data and enhance patient care.
The rise in healthcare expenditure globally, the increase in incidence of chronic diseases, the growing need for effective disease management further drives the growth of global population health management market. However, the lack of proper regulatory framework for population health management are expected to hamper the market growth.
The Visiongain report analyst commented “The increased demand for patient-centric care and implementation of value-based reimbursement have led to the need for better management and analysis of patient data. The increase in incidence of chronic diseases, need for better disease management, and rise in healthcare expenditure further drives the growth of the population health management market”.
The report covers a detailed competitive outlook that includes market share and company profiles of key players operating in the global market. Key players profiled in the report include Cerner Corporation, Epic Systems Corporation, Koninklijke Philips, I2I Population Health, Health Catalyst, Optum, Enli Health Intelligence, Eclinicalworks, Allscripts Healthcare Solutions, and IBM Corporation.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
As lockdowns were imposed in all the countries, diagnosis rates went down in majority of countries during the year hitting the drug sales for some period. Although lockdown measures have been eased up in most countries by mid-year 2020, this trend is expected to continue beyond 2020, stock up of medicines by patients is likely to propel the drug sales in majority of the developed economies, which account for majority of rare diseases.
02 March 2021
Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Jan 2021.
26 February 2021
The global bile duct cancer drug market has been growing considerably owing to the rising incidence and prevalence rate of bile duct cancer patients worldwide, technological advancement in drug development, and healthcare spending.
22 February 2021
The global Big Data Analytics in Healthcare market has been growing considerably owing to the rising technological advancement, growing investment, and cohesive government policies.